1-6 of 6
Erik H.J.G. Aarntzen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es, Sophie L. Gerritse, Lindsay Angus, Sandra Heskamp, Ingrid M.E. Desar, C. Willemien Menke-van der Houven van Oordt, Astrid A.M. van der Veldt, Anne I.J. Arens, Adrienne H. Brouwers, Bertha Eisses, Peter F.A. Mulders, Otto S. Hoekstra, Gerben J.C. Zwezerijnen, Winette T.A. van der Graaf, Erik H.J.G. Aarntzen, Wim J.G. Oyen, Carla M.L. van Herpen
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (3): 592–601.
https://doi.org/10.1158/1078-0432.CCR-22-0921
Published: 01 February 2023
View articletitled, [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
Open the PDF for [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Florian Wimmers, Erik H.J.G. Aarntzen, Tjitske Duiveman-de Boer, Mandy W.M.M. van de Rakt, Nicole M. Scharenborg, Annemiek J. de Boer, Jeanette M. Pots, Michel A.M. Olde Nordkamp, Tom G.M. van Oorschot, Jurjen Tel, Gregor Winkels, Katja Petry, Willeke A.M. Blokx, Michelle M. van Rossum, Marieke E.B. Welzen, Roel D.M. Mus, Sandra A.J. Croockewit, Rutger H.T. Koornstra, Joannes F.M. Jacobs, Sander Kelderman, Christian U. Blank, Winald R. Gerritsen, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (9): 2155–2166.
https://doi.org/10.1158/1078-0432.CCR-15-2205
Published: 01 May 2016
View articletitled, Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Open the PDF for Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells in another window
Includes: Supplementary data
Journal Articles

Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma

Henning Zelba, Benjamin Weide, Alexander Martens, Evelyna Derhovanessian, Jithendra Kini Bailur, Christina Kyzirakos, Annette Pflugfelder, Thomas K. Eigentler, Anna Maria Di Giacomo, Michele Maio, Erik H.J.G. Aarntzen, Jolanda de Vries, Antje Sucker, Dirk Schadendorf, Petra Büttner, Claus Garbe, Graham Pawelec
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4390–4399.
https://doi.org/10.1158/1078-0432.CCR-14-1015
Published: 13 August 2014
View articletitled, Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma
Open the PDF for Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma in another window
Includes: Supplementary data
Journal Articles

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

Erik H.J.G. Aarntzen, Mangala Srinivas, Fernando Bonetto, Luis J. Cruz, Pauline Verdijk, Gerty Schreibelt, Mandy van de Rakt, W. Joost Lesterhuis, Maichel van Riel, Cornelius J.A. Punt, Gosse J. Adema, Arend Heerschap, Carl G. Figdor, Wim J. Oyen, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1525–1533.
https://doi.org/10.1158/1078-0432.CCR-12-1879
Published: 14 March 2013
View articletitled, Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Open the PDF for Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells in another window
Includes: Supplementary data
Journal Articles

Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Annechien J.A. Lambeck, Erik H.J.G. Aarntzen, Joannes F.M. Jacobs, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Annemiek J. de Boer, Sandra Croockewit, Michelle M. van Rossum, Roel Mus, Wim J.G. Oyen, Otto C. Boerman, Sophie Lucas, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5725–5735.
https://doi.org/10.1158/1078-0432.CCR-11-1261
Published: 01 September 2011
View articletitled, Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Open the PDF for Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

Pauline Verdijk, Erik H.J.G. Aarntzen, W. Joost Lesterhuis, A.C. Inge Boullart, Ellemieke Kok, Michelle M. van Rossum, Simon Strijk, Femke Eijckeler, Johannes J. Bonenkamp, Joannes F.M. Jacobs, Willeke Blokx, J. Han J.M. vanKrieken, Irma Joosten, Otto C. Boerman, Wim J.G. Oyen, Gosse Adema, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2531–2540.
https://doi.org/10.1158/1078-0432.CCR-08-2729
Published: 01 April 2009
View articletitled, Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Open the PDF for Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients in another window